China    manufacturer

Hangzhou AllTest Biotech CO.,LTD 

      Your Reliable Rapid Test Partner!

Sales & Support
Request A Quote - Email
Select Language
English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Arabic
Hindi
Turkish
Indonesian
Vietnamese
Thai
Bengali
Persian
Polish
China good quality Custom Monoclonal Antibody on sale China good quality Hybridoma Monoclonal Antibody on sale
I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

I'm Online Chat Now

Accurate Benzodiazepines BZO Drug Abuse Test Kit Rapid Test In Urine

Product Details:

Place of Origin:CHINA
Brand Name:AllTest
Certification:CE, FDA 510K
Model Number:DBZ-101/DBZ-102/DBZ-114

Payment & Shipping Terms:

Minimum Order Quantity:500
Packaging Details:40T/kit or 50T/kit
Supply Ability:100 Million a year
Detailed Product Description
Format: Cassette/Dipstick/Panel Specimen: Urine
Cut-off: 100 Ng/mL, 200 Ng/mL, 300 Ng/mL* Size: 40T/kit Or 50T/kit
Color: Yellow Storage: 2-30°C

 
 
A rapid test with CE certified​ for the qualitative detection of Benzodiazepines in human urine. For medical and other professional in vitro diagnostic use only.
 
 

Applications: 

 

The BZO Rapid Test (Urine) is a rapid chromatographic immunoassay for the detection of Oxazepam (major metabolite) in urine at a cut-off concentration of 300ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert.
This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

 

 

Description: 

 

Benzodiazepines are medications that are frequently prescribed for the symptomatic treatment of anxiety and sleep disorders. They produce their effects via specific receptors involving a neurochemical called gamma aminobutyric acid (GABA). Because they are safer and more effective, Benzodiazepines have replaced Barbiturates in the treatment of both anxiety and insomnia. Benzodiazepines are also used as sedatives before some surgical and medical procedures, and for the treatment of seizure disorders and alcohol withdrawal.
Risk of physical dependence increases if Benzodiazepines are taken regularly (e.g., daily) for more than a few months, especially at higher than normal doses. Stopping abruptly can bring on such symptoms as trouble sleeping, gastrointestinal upset, feeling unwell, loss of appetite, sweating, trembling, weakness, anxiety and changes in perception. Only trace amounts (less than 1%) of most Benzodiazepines are excreted unaltered in the urine; most of the concentration in urine is conjugated drug. The detection period for the Benzodiazepines in the urine is 3-7 days.

 

How to use? 

 

Allow the test, urine specimen, and/or controls to reach room temperature (15-30°C) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the test cassette from the sealed pouch and use it within one hour.
2. Place the test cassette on a clean and level surface. Hold the dropper vertically and transfer 3 full drops of urine (approx. 120μL) to the specimen well (S) of the test cassette, and then start the timer. Avoid trapping air bubbles in the specimen well (S). See the illustration below.
3. Wait for the colored line(s) to appear. Read results at 5 minutes. Do not interpret the result after 10minutes.

Accurate Benzodiazepines BZO Drug Abuse Test Kit Rapid Test In Urine

【DIRECTIONS FOR PANEL USE】
Allow the test, urine specimen, and/or controls to reach room temperature (15-30ºC) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the test panel from the sealed pouch and use it within one hour.
2. Remove the cap.
3. With the arrow pointing toward the urine specimen, immerse the test panel vertically in the urine specimen for at least 10 to 15 seconds. Immerse the strip to at least the level of the wavy lines, but not above the arrow on the test panel.
4. Replace the cap and place the test panel on a non-absorbent flat surface.
5. Start the timer and wait for the colored line(s) to appear.
6. The result should be read at 5 minutes. Do not interpret the result after 10 minutes.

Accurate Benzodiazepines BZO Drug Abuse Test Kit Rapid Test In Urine

【DIRECTIONS FOR DIPSTICK USE】
Allow the test, urine specimen, and/or controls to reach room temperature (15-30ºC) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the test dipstick from the sealed pouch and use it within one hour.
2. With arrows pointing toward the urine specimen, immerse the test dipstick vertically in the urine specimen for at least 10-15 seconds. Do not pass the maximum line (MAX) on the Test Dipstick when immersing the strip. See the illustration below.
3. Place the test dipstick on a non-absorbent flat surface, start the timer and wait for the colored line(s) to appear. Read results at 5 minutes. Do not interpret the result after 10 minutes.

 

Accurate Benzodiazepines BZO Drug Abuse Test Kit Rapid Test In Urine

 

 

INTERPRETATION OF RESULTS

 

(Please refer to the illustration above)

 

NEGATIVE:* Two lines appear. One colored line should be in the control line region (C), and another apparent colored line should be in the test line region (T). A negative result indicates that the Benzodiazepines (BZO) concentration is below the detectable level.

 

*NOTE: The shade of color in the test line region (T) may vary, but it should be considered negative whenever there is even a faint colored line.

 

POSITIVE: One colored line appears in the control line region (C). No line appears in the test line region (T). A positive result indicates that the Benzodiazepines (BZO) concentration exceeds the detectable level.

 

INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test. If the problem persists, discontinue using the lot immediately and contact your local distributor.

 

 

 

Cat. No. Product Description Specimen Format Kit Size Cut-Off Status
DBZ-102 Benzodiazepines (BZO) Rapid Test Cassette Urine Cassette 40 T 100 ng/mL, 200 ng/mL,
300 ng/mL*
CE/FDA
DBZ-114 Benzodiazepines (BZO) Rapid Test Panel Urine Panel 40 T CE/FDA
DBZ-101 Benzodiazepines (BZO) Rapid Test Dipstick Urine Dipstick 50 T CE/FDA

Contact Details
Hangzhou AllTest Biotech CO.,LTD

Tel:86-571-56267891

Fax:86-571-56267856

Contact Person: Mrs. Selina

Send your inquiry directly to us (0 / 3000)